Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?
about
Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countriesEliminating the Neglected Tropical Diseases: Translational Science and New Technologies.Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel AdministrationSpecies-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay.Sustaining the Control of Schistosoma mansoni in Western Côte d'Ivoire: Baseline Findings Before the Implementation of a Randomized Trial.Schistosoma haematobium and soil-transmitted Helminths in Tana Delta District of Kenya: infection and morbidity patterns in primary schoolchildren from two isolated villages.North American paragonimiasis: epidemiology and diagnostic strategies.Natural products with antischistosomal activity.Susceptibility of Snails to Infection with Schistosomes is influenced by Temperature and Expression of Heat Shock Proteins.Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis.
P2860
Q24658590-796A19C3-E05D-4E7C-AF29-39B912EB09DDQ26765026-8493DCB4-71EC-4E3A-8108-5EC91AC401A4Q28552663-2253F5AD-7A84-41B3-95D6-6D3DF81312D4Q35751412-4CF59A83-10A8-40B9-831F-68391D657411Q35849449-730B2088-4E0D-49E5-AB3C-793C101B8DDAQ35914043-9BD2780B-F876-4338-A266-1B6BBE345BC5Q38401810-1561C45D-0302-4150-8DE3-58C1FD20ADBBQ38495064-C4EB42BE-5A13-40DA-A2FD-0CB291FC5270Q39141752-4E0A9E32-F47E-4FE4-B4B4-9B5706818F77Q41992861-634FCA07-DF6F-4E3E-B406-532977ECD8DEQ47724284-06428578-1F28-41D5-A1AF-8B999D9AC57FQ48252966-6ABC7485-11C5-4D53-BE37-DCDCB0FF10C5
P2860
Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Morbidity control of schistoso ...... ake to move on to elimination?
@ast
Morbidity control of schistoso ...... ake to move on to elimination?
@en
Morbidity control of schistoso ...... ake to move on to elimination?
@nl
type
label
Morbidity control of schistoso ...... ake to move on to elimination?
@ast
Morbidity control of schistoso ...... ake to move on to elimination?
@en
Morbidity control of schistoso ...... ake to move on to elimination?
@nl
prefLabel
Morbidity control of schistoso ...... ake to move on to elimination?
@ast
Morbidity control of schistoso ...... ake to move on to elimination?
@en
Morbidity control of schistoso ...... ake to move on to elimination?
@nl
P2860
P356
P1476
Morbidity control of schistoso ...... ake to move on to elimination?
@en
P2093
Daniel G Colley
P2860
P2888
P356
10.2149/TMH.2014-S04
P433
P577
2014-06-01T00:00:00Z
P5875
P6179
1014473773